Investors seeking a steadily growing passive income stream want to turn their heads toward the healthcare sector. Unlike with ...

We came across a bullish thesis on AbbVie Inc. (ABBV) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, ...

The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

There are several Canadian companies that offer funds that invest in U.S. stocks with a covered call strategy. One is ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

Japanese drugmaker Sumitomo Pharma Company has concluded a co-promotion collaboration partner agreement with US healthcare ...